Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal

por Gupta, Vishal, Canovatchel, William, Lokesh, B. N., Santani, Ravi, Garodia, Nishant
Publicado 2017

A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus

por Prasanna Kumar, K. M., Ghosh, Sujoy, Canovatchel, William, Garodia, Nishant, Rajashekar, Sujith
Publicado 2017